Back to Search
NICHOLAS DAWSON, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1386347193Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
A198684(CA)
Research & Publications (20)
Novel treatment methods for localized prostate cancer: hypofractionated robotic radiation therapy and adjuvant chemotherapy.
PMID 19589034·Expert Rev Anticancer Ther·2009
6-review
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004.
PMID 18824434·Clin Genitourin Cancer·2008
3-trial
New molecular targets in advanced prostate cancer.
PMID 16831072·Expert Rev Anticancer Ther·2006
6-review
Signaling pathways mediating VEGF165-induced calcium transients and membrane depolarization in human endothelial cells.
PMID 16581961·FASEB J·2006
8-other
A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma.
PMID 15585612·Clin Cancer Res·2004
3-trial
Novel approaches to treat asymptomatic, hormone-naive patients with rising prostate-specific antigen after primary treatment for prostate cancer.
PMID 14747048·Urology·2003
6-review
Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease.
PMID 12739996·Expert Opin Pharmacother·2003
6-review
Bisphosphonates: their evolving role in the management of prostate cancer-related bone disease.
PMID 12172429·Curr Opin Urol·2002
6-review
A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181.
PMID 10679652·Cancer·2000
3-trial
Sex influences the effect of a lifelong increase in serotonin transporter function on cerebral metabolism.
PMID 19326435·J Neurosci Res·2009
7-preclinical
Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
PMID 19042080·Eur Urol·2009
3-trial
Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables.
PMID 19135859·J Clin Epidemiol·2009
8-other
Patient age, well-being, perspectives, and care practices in the early treatment phase for late-stage cancer.
PMID 18840801·J Gerontol A Biol Sci Med Sci·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 975 SERENO DR
VALLEJO, CA 94589 - Phone
- (707) 651-4071
Quick Facts
- NPI
- 1386347193
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile